BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  PDL BioPharma Reports 2019 Third Quarter Financial Results

  Revenues of $44.2 million includes continued growth from LENSAR and strong contribution from royalty assets

  November 6, 2019

   · 

  17 min read
• Business

  AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results

  Exceeded 125 REMS-certified facilities two months ahead of year-end goal

  November 6, 2019

   · 

  10 min read
• Business

  Invitae Reports $56.5 Million in 2019 Quarterly Revenue Driven by 129,000 Samples

  Invitae Corporation, a leading medical genetics company, announced financial and operating results for the third quarter ended September 30, 2019.

  November 6, 2019

   · 

  16 min read
• Biotech Bay

  Revance to Participate in the Credit Suisse 28th Annual Healthcare Conference

  Revance Therapeutics, Inc., a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, announced that the company will participate in the Credit Suisse 28th Annual Healthcare Conference, in Scottsdale, AZ.

  November 6, 2019

   · 

  2 min read
• Biotech Beach

  Inogen Announces Participation in Stifel 2019 Healthcare Conference

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in the Stifel 2019 Healthcare Conference in New York.

  November 6, 2019

   · 

  1 min read
• Business

  Dexcom Reports Third Quarter 2019 Financial Results

  DexCom, Inc. reported its financial results as of and for the quarter ended September 30, 2019.

  November 6, 2019

   · 

  16 min read
• Business

  Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

  Breakthrough Therapy Designation for Maralixibat for the Treatment of Pruritus Associated with Alagille Syndrome Granted

  November 6, 2019

   · 

  6 min read
• Business

  Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019

  Aurinia Pharmaceuticals Inc. announced that it will release its third quarter 2019 financial results on Thursday, November 14, 2019, after the market closes.

  November 6, 2019

   · 

  1 min read
• Business

  Sangamo Therapeutics Reports Third Quarter 2019 Financial Results

  Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported third quarter 2019 financial results and recent business highlights

  November 6, 2019

   · 

  9 min read
• Business

  Quanterix Corporation Releases Operating Results for Third Quarter 2019

  Strong revenue growth and successful early launch of new HD-X Analyzer

  November 6, 2019

   · 

  11 min read